PFE: Key Statistics for PFIZER INC - Yahoo! Finance http://finance ...

[Pages:10]PFE: Key Statistics for PFIZER INC - Yahoo! Finance



Yahoo! My Yahoo! Mail

Search

Sign In Finance Home - Help

New User?Sign Up

Tuesday, September 13, 2005, 4:57PM ET - U.S. Markets Closed. Dow -0.80% Nasdaq -0.51%

To track stocks & more, Register

Quotes & Info

Enter Symbol(s): e.g. YHOO, ^DJI

GO Symbol Lookup | Finance Search

Pfizer Inc. (PFE)

Fidelity Brokerage Services ? New low commissions ? tradesmarter

At 4:00PM ET: 25.98 0.36 (1.37%)

Key Statistics

Get Key Statistics for:

Data provided by Capital IQ, except where noted.

VALUATION MEASURES

Market Cap (intraday): Enterprise Value (13-Sep-05)3: Trailing P/E (ttm, intraday): Forward P/E (fye 31-Dec-06) 1: PEG Ratio (5 yr expected): Price/Sales (ttm): Price/Book (mrq): Enterprise Value/Revenue (ttm)3: Enterprise Value/EBITDA (ttm)3:

191.49B 192.53B 19.64 12.03 2.22 3.64 2.98 3.61 8.688

ADVERTISEMENT

FINANCIAL HIGHLIGHTS

Fiscal Year Fiscal Year Ends: Most Recent Quarter (mrq):

Profitability Profit Margin (ttm): Operating Margin (ttm):

Management Effectiveness Return on Assets (ttm): Return on Equity (ttm):

Income Statement Revenue (ttm): Revenue Per Share (ttm): Qtrly Revenue Growth (yoy): Gross Profit (ttm): EBITDA (ttm): Net Income Avl to Common (ttm): Diluted EPS (ttm):

31-Dec 03-Jul-05

18.64% 31.55%

9.05% 15.02%

53.27B 7.163 1.20% 44.98B 22.16B 9.91B 1.32

TRADING INFORMATION

Stock Price History Beta: 52-Week Change3: S&P500 52-Week Change3: 52-Week High (14-Sep-04)3: 52-Week Low (17-Dec-04)3: 50-Day Moving Average3: 200-Day Moving Average3:

Share Statistics Average Volume (3 month)3: Average Volume (10 day)3: Shares Outstanding: Float: % Held by Insiders4:

GO

N/A -18.02% 7.66% 32.63 21.99 26.02 26.99 24,344,100 24,830,000 7.37B N/A 0.11%

1 of 2

9/13/2005 5:11 PM

PFE: Key Statistics for PFIZER INC - Yahoo! Finance



Qtrly Earnings Growth (yoy):

Balance Sheet Total Cash (mrq): Total Cash Per Share (mrq): Total Debt (mrq): Total Debt/Equity (mrq): Current Ratio (mrq): Book Value Per Share (mrq):

Cash Flow Statement From Operations (ttm): Free Cashflow (ttm):

21.00%

14.57B 1.977 12.78B 0.196 1.488 8.844

18.15B 9.37B

View Financials (provided by EDGAR Online): Income Statement - Balance Sheet Cash Flow

WILink Presents Free Annual Report for PFE

% Held by Institutions4: Shares Short (as of 12-Jul-05)3: Short Ratio (as of 12-Jul-05)3: Short % of Float (as of 12-Jul-05)3: Shares Short (prior month)3:

Dividends & Splits Forward Annual Dividend Rate5: Forward Annual Dividend Yield5: Trailing Annual Dividend Rate3: Trailing Annual Dividend Yield3: 5 Year Average Dividend Yield5: Payout Ratio5: Dividend Date3: Ex-Dividend Date5: Last Split Factor (new per old)2: Last Split Date3:

62.20% 42.05M 1.6 0.60% 40.17M

0.76 2.90% 0.91 3.45% 1.60% 55% 06-Sep-05 10-Aug-05 3:1 01-Jul-99

Add to Portfolio Set Alert Email to a Friend

Get Key Statistics for Another Symbol:

GO Symbol Lookup

? Annual Reports

? Sector Analysis

See Key Statistics Help for definitions of terms used.

Abbreviation Guide: K = Thousands; M = Millions; B = Billions mrq = Most Recent Quarter (as of 03-Jul-05) ttm = Trailing Twelve Months (as of 03-Jul-05) yoy = Year Over Year (as of 03-Jul-05) lfy = Last Fiscal Year (as of 31-Dec-04) fye = Fiscal Year Ending

1 = Data provided by Thomson; 2 = Data provided by EDGAR Online; 3 = Data derived from multiple sources or calculated by Yahoo! Finance; 4 = Data provided by Computershare; 5 = Data provided by Hemscott Americas

Copyright ? 2005 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy

Quotes delayed, except where indicated otherwise. Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.

Fundamental company data provided by Capital IQ . Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Financials data provided by Edgar Online .All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or

for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.

2 of 2

9/13/2005 5:11 PM

Research: Stocks: Evaluate a Stock: Fundamentals: Competitors

Competitive Analysis

...

2 of 3

Name

Pfizer Inc.

WYETH

Bristol-Myers Squibb Co.

Eli Lilly & Co. Merck & C

Industry

Current Share Price

Drug Manufacturers/ Drug Manufacturers/ Drug Manufacturers/ Drug Manufacturers/ Drug Manufa

Major

Major

Major

Major

25.98

45.20

24.86

55.52

Market Value

$194,139 mil

$61,251 mil

$48,368 mil

$64,571 mil

Revenues

$53,270 mil

$18,413 mil

$18,190 mil

$14,090 mil

Net Earnings

$9,930 mil

$1,712 mil

$2,434 mil

$1,237 mil

5-yr. Sales Growth

16.89%

6.16%

0.27%

5.51%

5-yr. Earnings Growth

8.66%

NA

-13.09%

-12.10%

Net Profit Margin

18.60%

9.30%

13.40%

8.80%

Short Interest

1.6

2.0

3.7

3.9

Est. EPS Growth Rate

8.4%

8.3%

5.4%

10.4%

Forward P/E

13.3

15.8

17.3

20.1

PEG

1.57

1.90

3.23

1.93

Price/Sales

3.66792040548 3.37778880931 2.69732380429 4.39600420162 2.9087876

Price/Cash Flow

13.3

25.3

14.4

34.0

Price/Book

2.97175799045 5.69566677711 4.47814665309 6.28817083147 3.6826474

ROE

14.7536286887% 16.213956394% 22.9838038386% 11.2245245066% 25.9494670

ROA

8.24066088222% 5.21224214325% 8.45856929042% 5.17133656942% 10.5318743

Dividend

$0.76

$0.92

$1.12

$1.52

Dividend Yield

2.81%

2.01%

4.53%

2.63%

Payout Ratio

54.5%

73.6%

91.8%

129.8%

Total Return (12-mos.)

-11.5%

24.6%

9.2%

-2.7%

Total Return (3-yr.)

-2.4%

52.3%

18.0%

10.5%

Beta

0.4

0.8

0.5

0.5

% Off 52-wk. High

-17.52%

-3.34%

-6.54%

-16.44%

% Above 52-wk. Low

18.14%

23.60%

9.27%

10.29%

On Balance Volume Index

100

101

114

128

Consensus

Analyst

moderate buy

Recommendation

moderate buy

moderate sell

moderate buy

9/13/2005 5:09 PM

Financials

...

Trade Futures For $3 - Default2.htm Free Real-Time Quotes, Charts, News Full and discount online trad

Headlines News

Quote Monitor Message Boards Charts Level 2 Desktop Financials Screener Alerts Commodities Futures Data Trading Signals FOREX Reports Training Money Words Users of Microsoft Java VM may get asked to accept a new security certificate; this is normal, please select Yes. DavidW

Financials 09/13/2005 5:18PM

Pfizer (NYSE)

NYSE:PFE

Data Downloads

OK Search Stocks A-Z Search by Sector Sector Sheet

Pfizer Inc.

Company Name: Ticker Symbol: WWW Address: CEO: No. of Employees: Common Issue Type:

PFIZER INC PFE Henry A. McKinnell 115,000 CS

Company Data Quarterly Reports Annual Reports

Business Description: A research-based, global pharmaceutical company that discovers, develops, manufactures and markets leading prescription medicines for humans and animals as well as many of the world's best-known consumer healthcare products.

Industry Information:

DRUGS - Drug Manufacturers - Major [more like this]

Price 25.98 Market Cap (mil) 194,065.3

Day Change -0.36

Shares Outstanding (mil) 7,370.5

Bid Ask Open

-

- 26.34

Beta EPS DPS

0.44 1.49 0.68

High Low

Volume

26.65 26.21 19645500

P/E Yield 52-Wks-Range

19.9 2.9 32.63 - 21.99

KEY FIGURES (Latest Twelve Months - LTM)

Yesterday's Close

26.33

PE Ratio - LTM Market Capitalisation (mil)

19.9 194,065.3

Latest Shares Outstanding (mil)

7,370.5

Earnings pS (EPS)

1.49

Dividend pS (DPS)

0.68

Dividend Yield

2.9

Dividend Payout Ratio

46

Revenue per Employee

456,661

Effective Tax Rate

19.0

Float (mil)

7,362.1

Float as % of Shares Outstanding Foreign Sales (mil)

99.9 22,977

Domestic Sales (mil)

29,539

Selling, General & Adm/tive (SG&A) as % of Revenue

32.00

Research & Devlopment (R&D) as % of Revenue

14.70

Gross Profit Margin

88.0

EBITDA Margin

41.3

Pre-Tax Profit Margin

25.2

Assets Turnover

0.5

Balance Sheet (at a glance) in Millions

DIVIDEND INFO

Ex-Dividend Date Type of Payment Dividend Rate Current Dividend Yield 5-Y Average Dividend Yield

2005/08/10 Cash Payment

0.76 2.9 1.6

Payout Ratio

46.0

5-Y Average Payout Ratio

58.0

Share price performance previous 3 years

1 of 5

9/13/2005 5:19 PM

Financials

...

Return on Assets (ROA) Return on Equity (ROE) Return on Capital Invested (ROCI) Current Ratio Leverage Ratio (Assets/Equity) Interest Cover Total Debt/Equity (Gearing Ratio) LT Debt/Total Capital Working Capial pS Cash pS Book-Value pS Tangible Book-Value pS Cash Flow pS Free Cash Flow pS

8.8

15.2

14.0

1.5

1.7

39.6

0.20

8.0

1.49

0.17

8.84 KEY FIGURES (Latest Twelve Months - LTM) 1.59 Cont.

2.07 Price/Book Ratio

2.98

1.22 Price/Tangible Book Ratio

16.56

Price/Cash Flow

12.7

Price/Free Cash Flow

21.6

P/E as % of Industry Group

45.0

P/E as % of Sector Segment

91.0

PRICE/VOLUME 1 Week 4 Weeks 13 Weeks 26 Weeks 52 Weeks YTD Moving Average

High -

26.65 29.21 29.21 32.63 29.21 5-Days 26.07

Low -

24.76 24.76 24.76 21.99 23.80 10-Days 25.63

Close -

26.16 27.68 26.36 31.86

10-Weeks

26.32

% Price Chg 3.9 0.6 -4.9 -0.1 -17.4 -2.1

30-Weeks 26.94

% Price Chg vs. Mkt. 102 100 92 97 75 96

200-Days 26.69

Avg. Daily Vol 232,785 228,164 240,757 238,895 293,765 259,132

Beta (60-Mnth) 0.44

Total Vol 1,093,523 4,335,120 15,167,704 30,100,742 74,028,846 45,088,922 Beta (36-Mnth)

0.63

GROWTH RATES

Revenue Income Dividend Capital Spending R&D Normalized Inc.

5-Year Growh 16.89

8.66 15.31 18.76 17.38 9.69

R? of 5-Year Growth

91.0 12.2 97.8 NA NA NA

3-Year Growth

17.19 -0.44 11.89 32.06 15.77 5.51

CHANGES

Revenue % Earnings % EPS % EPS $

YTD vs. Last YTD

3.0 -27.6 -25.0 -0.17

Curr Qtr vs. Qtr 1-Yr ago

1.2 21.0 23.7 0.09

Annual vs. Last Annual

16.2 188.4 175.9 0.95

SOLVENCY RATIOS

SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)

Net Working Capital Ratio

10.70

Current Ratio

1.5

Quick Ratio (Acid Test)

1.1

Liquidity Ratio (Cash)

0.75

Receivables Turnover

5.5

Average Collection Period

65

Working Capital/Equity

19.4

Working Capital pS

1.77

Cash-Flow pS

2.20

Free Cash-Flow pS

0.86

FINANCIAL STRUCTURE RATIOS

2 of 5

9/13/2005 5:19 PM

Financials

Altman's Z-Score Ratio Financial Leverage Ratio (Assets/Equity) Debt Ratio Total Debt/Equity (Gearing Ratio) LT Debt/Equity LT Debt/Capital Invested LT Debt/Total Liabilities Interest Cover Interest/Capital Invested

VALUATION RATIOS MULTIPLES

PQ Ratio Tobin's Q Ratio Current P/E Ratio - LTM Enterprise Value (EV)/EBITDA Enterprise Value (EV)/Free Cash Flow Dividend Yield Price/Tangible Book Ratio - LTM Price/Book Ratio - LTM Price/Cash Flow Ratio Price/Free Cash Flow Ratio - LTM Price/Sales Ratio P/E Ratio (1 month ago) - LTM P/E Ratio (26 weeks ago) - LTM P/E Ratio (52 weeks ago) - LTM 5-Y High P/E Ratio 5-Y Low P/E Ratio 5-Y Average P/E Ratio Current P/E Ratio as % of 5-Y Average P/E P/E as % of Industry Group P/E as % of Sector Segment Current 12 Month Normalized P/E Ratio - LTM

PER SHARE FIGURES

LT Debt pS Current Liabilities pS Tangible Book Value pS - LTM Book Value pS - LTM Capital Invested pS Cash pS - LTM Cash Flow pS - LTM Free Cash Flow pS - LTM Earnings pS (EPS)

OPERATING RATIOS PROFITABILITY RATIOS

Free Cash Flow Margin Free Cash Flow Margin 5YEAR AVG Net Profit Margin Net Profit Margin - 5YEAR AVRG. Equity Productivity

3 of 5

...

3.20 1.8

44.8 0.27 0.11 38.3 13.1 41.3

1.8

253.72 1.57

19.90 10.39 35.48

2.9 16.56

2.98 12.7 21.6 3.70 20.2 17.7 30.3 83.5 14.8 42.8

46 45.0 91.0 16.3

0.97 3.54 1.59 8.84 10.25 0.17 2.07 1.22 1.49

12.18 11.70

21.6 18.9 0.77

9/13/2005 5:19 PM

Financials

...

Return on Equity (ROE) Return on Equity (ROE) - 5YEAR AVRG. Capital Invested Productivity Return on Capital Invested (ROCI) Return on Capital Invested (ROCI) - 5YEAR AVRG. Assets Productivity Return on Assets (ROA) Return on Assets (ROA) - 5YEAR AVRG. Gross Profit Margin Gross Profit Margin - 5YEAR AVRG. EBITDA Margin - LTM EBIT Margin - LTM Pre-Tax Profit Margin Pre-Tax Profit Margin - 5YEAR AVRG. Effective Tax Rate Effective Tax Rate - 5YEAR AVRG.

EFFICIENCY RATIOS

Cash Conversion Cycle Revenue per Employee Net Income per Employee Average Collection Period Receivables Productivity Day's Inventory Turnover Ratio Inventory Productivity Inventory/Sales Accounts Payble/Sales Assets/Revenue Net Working Capital Productivity Fixed Assets Productivity Total Assets Productivity Revenue per $ Cash Revenue per $ Plant Revenue per $ Common Equity Revenue per $ Capital Invested Selling, General & Adm/tive (SG&A) as % of Revenue SG&A Expense as % of Revenue - 5YEAR AVRG. Research & Devlopment (R&D) as % of Revenue R&D Expense as % of Revenue - 5YEAR AVRG.

16.7 19.4 0.70 15.0 17.5 0.40

9.2 10.1 88.0 87.0 41.3 25.8 26.7 23.5 19.0 30.2

456 456,661

98,791 69 5.5

387 0.9 12.7 5.09 2.50 3.97 0.63 0.4 29.05 2.86 0.77 0.70 32.2 34.3 14.6 14.6

4 of 5

9/13/2005 5:19 PM

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download